Quarterly report pursuant to Section 13 or 15(d)

Transactions Affecting Stockholders' Equity

v3.19.2
Transactions Affecting Stockholders' Equity
6 Months Ended
Jun. 30, 2019
Equity [Abstract]  
Transactions Affecting Stockholders' Equity

Note 4 – Transactions Affecting Stockholders’ Equity

 

Our authorized capital stock consists of 50 million shares of Common Stock, $0.0005 par value (“Common Stock”), and 1 million shares of preferred stock, $0.0005 par value (“Preferred Stock”).

 

Preferred Stock

 

The Preferred Stock authorized under our certificate of incorporation may be issued from time to time in one or more series. As of June 30, 2019, no shares of Preferred Stock have been issued. Our board of directors has the full authority permitted by law to establish, without further stockholder approval, one or more series of Preferred Stock and the number of shares constituting each such series and to fix by resolution voting powers, preferences and relative, participating, optional and other special rights of each series of Preferred Stock, and the qualifications, limitations or restrictions thereof, if any. Subject to the limitation on the total number of shares of Preferred Stock that we have authority to issue under our certificate of incorporation, the board of directors is also authorized to increase or decrease the number of shares of any series, subsequent to the issue of that series, but not below the number of shares of such series then-outstanding. In case the number of shares of any series is so decreased, the shares constituting such decrease will resume the status that they had prior to the adoption of the resolution originally fixing the number of shares of such series. We may amend from time to time our certificate of incorporation and bylaws to increase the number of authorized shares of Preferred Stock or Common Stock or to make other changes or additions to our capital structure or the terms of our capital stock.

 

Common Stock Dividend

 

On May 7, 2018, the Board declared a special cash dividend of $1.00 per share on the Company’s Common Stock resulting payable on June 5, 2018 to holders of record of the Company’s Common Stock on June 6, 2018. On June 5, 2018, we made cash payment of $11.7 million.

 

On December 24, 2018, the Board declared a special cash dividend of $0.25 per share on the Company’s Common Stock resulting in $2.9 million payable on January 24, 2019 to holders of record of the Company’s Common Stock on January 10, 2019. On January 24, 2019, we made cash payment of $2.9 million.

 

The 2010 Directors’ Equity Compensation Plan

 

On May 5, 2010, our stockholders approved the 2010 Directors’ Equity Compensation Plan, which was subsequently amended and restated by our stockholders (the “2010 Directors’ Plan”). A primary purpose of the 2010 Directors’ Plan is to provide us with the ability to pay all or a portion of the fees of directors in restricted stock instead of cash. The 2010 Directors’ Plan provides that the total number of shares of Common Stock that may be issued under the 2010 Directors’ Plan is equal to 675,000 shares.

 

During the three and six months ended June 30, 2019, 3,571 and 10,737 shares of restricted stock were granted to our directors under the 2010 Directors’ Plan. We recorded $34,000 of director fees during the six months ended June 30, 2019 in connection with these grants, which represented the fair value of the shares calculated based on the average closing price of the Company’s shares of Common Stock for the first five trading days of the quarter in which the Board fee was earned. No shares were granted during the three and six months ended June 30, 2018.

 

As of June 30, 2019, there were 372,123 shares of Common Stock that may be issued pursuant to the terms of the 2010 Directors’ Plan.

 

The 2010 Equity Compensation Plan

 

On May 5, 2010, our stockholders approved the 2010 Equity Compensation Plan, which has been subsequently amended and restated by our stockholders (the “2010 Plan”). The 2010 Plan provides that the total number of shares of Common Stock that may be issued under the 2010 Plan is 3.9 million shares.

 

No options were granted under the 2010 Plan for the three and six months ended June 30, 2019. During the three and six months ended June 30, 2018, we granted 30,000 options, exercisable at $2.35 per share and subject to vesting over a three-year term, to a consultant pursuant to the terms of the 2010 Plan.

 

As of June 30, 2019, there were 649,500 options outstanding and 661,159 options available to be issued pursuant to the terms of the 2010 Plan. We will recognize approximately $345,000 of share-based compensation expense over a weighted average period of 2.3 years.

 

The 2018 Stock Incentive Plan

 

On April 12, 2018, our stockholders approved the 2018 Stock Incentive Plan (the “2018 Stock Plan”). The 2018 Stock Plan provides for the grant of incentive stock options to eligible employees of the Company, and for the grant of nonstatutory stock options to eligible employees, directors and consultants. The purpose of the 2018 Stock Plan is to advance the interests of the Company and its stockholders by providing an incentive to attract, retain, and reward persons performing services for the Company and by motivating such persons to contribute to the growth and profitability of the Company. The 2018 Stock Plan provides that the total number of shares that may be issued pursuant to the 2018 Stock Plan is 2.3 million shares. As of September 30, 2018, all 2.3 million shares have been granted in the form of stock options to Ted Karkus (the “CEO Option”), our Chief Executive Officer and no stock options have been exercised under the 2018 Stock Plan. We use the Black-Scholes option pricing model to determine the fair value of the stock options at the date of grant. Based upon our limited historical experience, we determined the expected term of the stock option grants to be 4.5 years, calculated using the “simplified” method in accordance with the SEC Staff Accounting Bulletin 110. We use the “simplified” method since our historical data does not provide a reasonable basis upon which to estimate expected term. We will recognize approximately $835,000 of share-based compensation expense over a weighted average period of 1.7 years.

  

The 2018 Plan requires certain proportionate adjustments to be made to the stock options granted under the 2018 Plan upon the occurrence of certain events, including a special distribution (whether in the form of cash, shares, other securities, or other property) in order to maintain parity. Accordingly, the Compensation Committee of the board of directors, as required by the terms of the 2018 Stock Plan, adjusted the terms of the CEO Option, such that the exercise price of the CEO Option was reduced from $3.00 per share to $2.00 per share, effective as of June 5, 2018, the date the special $1.00 special cash dividend was paid to stockholders. The exercise price of the CEO Option was further reduced from $2.00 to $1.75 per share, effective as of January 24, 2019, the date the $0.25 special cash dividend was paid to stockholders.

 

The following table summarizes stock options activity during the six months ended June 30, 2018 and 2019 for both the 2010 Plan and 2018 Stock Plan (in thousands, except per share data):

 

    Number of Shares     Weighted Average Exercise Price     Weighted Average Remaining Contractual Life (in years)     Total Intrinsic Value  
Outstanding as of January 1, 2018     980     $ 1.82       4.8     $ 31  
Granted     2,330       2.00       -       -  
Cashless exercised     (250 )     1.86       -       -  
Cash exercised     (240 )     1.41       -       -  
Outstanding as of June 30, 2018     2,820     $ 2.00       4.9     $ 422  
Options vested and exercisable     539     $ 1.88       2.4     $ 150  

 

    Number of Shares     Weighted Average Exercise Price     Weighted Average Remaining Contractual Life (in years)     Total Intrinsic Value  
Outstanding as of January 1, 2019     2,980     $ 1.82       4.8     $ 3,235  
Forfeited     (80 )     2.87       -       -  
Outstanding as of June 30, 2019     2,900     $ 1.85       3.9     $ 4,450  
Options vested and exercisable     1,199     $ 1.88       3.8     $ 1,915